Tocilizumab is a drug used to treat severely ill COVID-19 patients.
The COVID-19 Committee has recommended that the government review its policy and purchase more of the drug. Chief Medical Officer Dr. Roshan Parasram explains the present policy and gives his take on the recommendations. Alicia Boucher has more in this report.
